Sign up to save your podcasts
Or
Share JAMA Ophthalmology : Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Ophthalmology : Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab
Interview with Arshad M. Khanani, MD, author of Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. Hosted by Neil Bressler, MD.
Related Content:
- Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Arshad M. Khanani, MD, author of Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema: The Pagoda Randomized Clinical Trial. Hosted by Neil Bressler, MD.
Related Content:
- Continuous Ranibizumab via Port Delivery System vs Monthly Ranibizumab for Treatment of Diabetic Macular Edema
More shows like JAMA Network
View all
Science Magazine Podcast
802 Listeners
JAMA Editors' Summary
129 Listeners
HBR IdeaCast
238 Listeners
NEJM This Week
316 Listeners
JAMA Author Interviews
165 Listeners
JAMA Clinical Reviews
480 Listeners
AFP: American Family Physician Podcast
683 Listeners
JAMA Pediatrics Editors' Summary
37 Listeners
Frankly Speaking About Family Medicine
256 Listeners
The Curbsiders Internal Medicine Podcast
3,342 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Neurology Author Interviews
15 Listeners
JAMA Psychiatry Author Interviews
24 Listeners
JAMA Surgery Author Interviews
6 Listeners
JAMA Medical News
88 Listeners
The Indicator from Planet Money
9,536 Listeners
Annals On Call Podcast
179 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
320 Listeners
Cardionerds: A Cardiology Podcast
415 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
AMA Update
91 Listeners
NEJM AI Grand Rounds
50 Listeners